Proprietary Synthesis of the C27-C35 Fragment of Eribulin and Its Elaboration toward the C14-C35 Subunit

被引:0
作者
Kim, U. Bin [1 ]
Samala, Srinivas [1 ]
Jung, Jaehun [1 ]
Song, Juyoung [1 ]
Lee, Kee-Young [1 ]
Oh, Chang-Young [1 ]
Shin, Hyunik [1 ]
机构
[1] YS Life Sci Co Ltd, R&D Ctr, Suwon 16675, Gyeonggi Do, South Korea
关键词
Eribulin; patent life cyclemanagement; sulfide; NHK coupling; oxetanes; proprietary processdevelopment; HALAVEN(R); SYNTHESIS;
D O I
10.1021/acs.oprd.4c00150
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Successful kilogram-scale preparation of the C27-C35 sulfide fragment of Eribulin was presented, which was elaborated with the C14-C26 fragment to produce a proprietary C14-C35 sulfide intermediate. The sulfide group was then oxidized to yield the known C14-C35 sulfone intermediate of Eribulin.
引用
收藏
页码:2832 / 2843
页数:12
相关论文
共 27 条
[1]   Natural products in drug discovery: advances and opportunities [J].
Atanasov, Atanas G. ;
Zotchev, Sergey B. ;
Dirsch, Verena M. ;
Supuran, Claudiu T. .
NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (03) :200-216
[2]  
Austad B., 2018, U.S. Patent, Patent No. [46965E1, 46965]
[3]  
Austad B., 2013, U.S. Patent, Patent No. [8445701B2, 8445701]
[4]   Process Development of Halaven®: Synthesis of the C14-C35 Fragment via Iterative Nozaki-Hiyama-Kishi Reaction-Williamson Ether Cyclization [J].
Austad, Brian C. ;
Benayoud, Farid ;
Calkins, Trevor L. ;
Campagna, Silvio ;
Chase, Charles E. ;
Choi, Hyeong-Wook ;
Christ, William ;
Costanzo, Robert ;
Cutter, James ;
Endo, Atsushi ;
Fang, Francis G. ;
Hu, Yongbo ;
Lewis, Bryan M. ;
Lewis, Michael D. ;
McKenna, Shawn ;
Noland, Thomas A. ;
Orr, John D. ;
Pesant, Marc ;
Schnaderbeck, Matthew J. ;
Wilkie, Gordon D. ;
Abe, Taichi ;
Asai, Naoki ;
Asai, Yumi ;
Kayano, Akio ;
Kimoto, Yuichi ;
Komatsu, Yuki ;
Kubota, Manabu ;
Kuroda, Hirofumi ;
Mizuno, Masanori ;
Nakamura, Taiju ;
Omae, Takao ;
Ozeki, Naoki ;
Suzuki, Taeko ;
Takigawa, Teiji ;
Watanabe, Tomohiro ;
Yoshizawab, Kazuhiro .
SYNLETT, 2013, 24 (03) :327-332
[5]   Commercial Manufacture of Halaven®: Chemoselective Transformations En Route to Structurally Complex Macrocyclic Ketones [J].
Austad, Brian C. ;
Calkins, Trevor L. ;
Chase, Charles E. ;
Fang, Francis G. ;
Horstmann, Thomas E. ;
Hu, Yongbo ;
Lewis, Bryan M. ;
Niu, Xiang ;
Noland, Thomas A. ;
Orr, John D. ;
Schnaderbeck, Matthew J. ;
Zhang, Huiming ;
Asakawa, Naoki ;
Asai, Naoki ;
Chiba, Hiroyuki ;
Hasebe, Takashi ;
Hoshino, Yorihisa ;
Ishizuka, Hiroyuki ;
Kajima, Takashi ;
Kayano, Akio ;
Komatsu, Yuki ;
Kubota, Manabu ;
Kuroda, Hirofumi ;
Miyazawa, Mamoru ;
Tagami, Katsuya ;
Watanabeb, Tomohiro .
SYNLETT, 2013, 24 (03) :333-337
[6]  
Benayoud F., 2016, U.S. Patent, Patent No. [9303050B2, 9303050]
[7]  
Benayoud F., 2020, U.S. Patent, Patent No. [RE47797E1, 47797]
[8]  
Benayoud F., 2013, U.S. Patent, Patent No. [8618313B2, 8618313]
[9]   Systematic review of Real-World effectiveness of eribulin for locally advanced or metastatic breast cancer [J].
Chabot, Isabelle ;
Zhao, Qi ;
Su, Yun .
CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (12) :2025-2036
[10]  
Chase C. E., 2014, U.S. Patent, Patent No. [8884031B2, 8884031]